These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25830297)

  • 21. Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis.
    Pantoja A; Fitzpatrick C; Vassall A; Weyer K; Floyd K
    Eur Respir J; 2013 Sep; 42(3):708-20. PubMed ID: 23258774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of implementation strategy in scaling up Xpert MTB/RIF for diagnosis of tuberculosis in the Indian health-care system: a transmission model.
    Salje H; Andrews JR; Deo S; Satyanarayana S; Sun AY; Pai M; Dowdy DW
    PLoS Med; 2014 Jul; 11(7):e1001674. PubMed ID: 25025235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of Tuberculosis Risk Factors among Bacteriologically Negative and Bacteriologically Confirmed Tuberculosis Patients from Five Regional Referral Hospitals in Uganda.
    Muttamba W; Kirenga B; Ssengooba W; Sekibira R; Katamba A; Joloba ML
    Am J Trop Med Hyg; 2019 Feb; 100(2):386-391. PubMed ID: 30594259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB).
    Reza TF; Nalugwa T; Farr K; Nantale M; Oyuku D; Nakaweesa A; Musinguzi J; Vangala M; Shete PB; Tucker A; Ferguson O; Fielding K; Sohn H; Dowdy D; Moore DAJ; Davis JL; Ackerman SL; Handley MA; Katamba A; Cattamanchi A
    Implement Sci; 2020 Apr; 15(1):24. PubMed ID: 32316993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis.
    Hanrahan CF; Haguma P; Ochom E; Kinera I; Cobelens F; Cattamanchi A; Davis L; Katamba A; Dowdy D
    Open Forum Infect Dis; 2016 Mar; 3(2):ofw068. PubMed ID: 27186589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pooling sputum from multiple individuals for Xpert® MTB/RIF testing: a strategy for screening high-risk populations.
    Zishiri V; Chihota V; McCarthy K; Charalambous S; Churchyard GJ; Hoffmann CJ
    Int J Tuberc Lung Dis; 2015 Jan; 19(1):87-90. PubMed ID: 25519796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?
    Trébucq A; Enarson DA; Chiang CY; Van Deun A; Harries AD; Boillot F; Detjen A; Fujiwara PI; Graham SM; Monedero I; Rusen ID; Rieder HL
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1567-72. PubMed ID: 22005110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level.
    Clouse K; Page-Shipp L; Dansey H; Moatlhodi B; Scott L; Bassett J; Stevens W; Sanne I; Van Rie A
    S Afr Med J; 2012 Sep; 102(10):805-7. PubMed ID: 23034211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.
    Bates M; O'Grady J; Maeurer M; Tembo J; Chilukutu L; Chabala C; Kasonde R; Mulota P; Mzyece J; Chomba M; Mukonda L; Mumba M; Kapata N; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Lancet Infect Dis; 2013 Jan; 13(1):36-42. PubMed ID: 23134697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberculosis among nomads in Adamawa, Nigeria: outcomes from two years of active case finding.
    John S; Gidado M; Dahiru T; Fanning A; Codlin AJ; Creswell J
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):463-8. PubMed ID: 25860003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation.
    Mwansa-Kambafwile J; Maitshotlo B; Black A
    PLoS One; 2017; 12(1):e0168659. PubMed ID: 28068347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis.
    Jha S; Ismail N; Clark D; Lewis JJ; Omar S; Dreyer A; Chihota V; Churchyard G; Dowdy DW
    PLoS One; 2016; 11(6):e0157554. PubMed ID: 27322162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosing Xpert MTB/RIF negative TB: impact and cost of alternative algorithms for South Africa.
    Schnippel K; Meyer-Rath G; Long L; Stevens WS; Sanne I; Rosen S
    S Afr Med J; 2013 Jan; 103(2):101-6. PubMed ID: 23374320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hidden costs of installing Xpert machines in a tuberculosis high-burden country: experiences from Nigeria.
    Abdurrahman ST; Emenyonu N; Obasanya OJ; Lawson L; Dacombe R; Muhammad M; Oladimeji O; Cuevas LE
    Pan Afr Med J; 2014; 18():277. PubMed ID: 25489371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of Xpert(®) MTB/RIF in sparsely populated rural settings.
    Van Den Handel T; Hampton KH; Sanne I; Stevens W; Crous R; Van Rie A
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):392-8. PubMed ID: 25859993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of the new WHO diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV prevalent settings: a multisite study in Uganda.
    Alamo ST; Kunutsor S; Walley J; Thoulass J; Evans M; Muchuro S; Matovu A; Katabira E
    Trop Med Int Health; 2012 Jul; 17(7):884-95. PubMed ID: 22575012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening new tuberculosis patients in Mali for rifampicin resistance at 2months.
    Diarra B; Cissé AB; Kodio O; Sanogo M; Baya B; Togo AC; Somboro A; Tolofoudié M; Degoga B; Keita ML; Diallo F; Nguiakam N; Coulibaly G; Bane S; Sarro YD; Doumbia S; Murphy RL; Diallo S; Dejong BC
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S42-S43. PubMed ID: 28043602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient costs for the diagnosis of tuberculosis in Brazil: comparison of Xpert MTB/RIF and smear microscopy.
    da Silva Antunes R; Pinto M; Trajman A
    Int J Tuberc Lung Dis; 2014 May; 18(5):547-51. PubMed ID: 24903791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of HIV among adults with pulmonary TB at a population level in Zambia.
    Chanda-Kapata P; Kapata N; Klinkenberg E; Grobusch MP; Cobelens F
    BMC Infect Dis; 2017 Mar; 17(1):236. PubMed ID: 28356081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.